Viral hepatitis in 2021:The challenges remaining and how we should tackle them

作     者：Rebecca Dunn Aaron Wetten Stuart McPherson Mhairi C Donnelly 

作者机构：GastroenterologyUniversity Hospital of North TeesStockton on Tees TS198PEUnited Kingdom Liver UnitFreeman HospitalNewcastle NE77DNUnited Kingdom Translational and Clinical Research InstituteNewcastle UniversityNewcastle NE17RUUnited Kingdom 

出 版 物：《World Journal of Gastroenterology》 (世界胃肠病学杂志（英文版）)

年 卷 期：2022年第28卷第1期

页      面：76-95页

核心收录：

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 100401[医学-流行病与卫生统计学] 10[医学] 

基　　金：MRC [MR/V037331/1] Funding Source: UKRI 

主　　题：Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E COVID-19 

摘      要：Viral hepatitis results in 1.4 million deaths *** World Health Organization(WHO)set an ambitious target to eliminate viral hepatitis by 2030,but significant challenges *** include inequalities in access to healthcare,reaching at risk populations and providing access to screening and effective *** around viral hepatitis persists and must be *** WHO goal of global elimination by 2030 is a worthy aim,but remains ambitious and the coronavirus 2019 pandemic undoubtedly has set back *** review article will focus on hepatitis A to E,highlighting problems that have been resolved in the field over the past decade,those that remain to be resolved and suggest directions for future problem solving and research.